Iria Pharma

60 Hazelwood Dr. Champaign, IL

Iria Pharma, LLC is dedicated to developing novel cancer-targeting technology and therapeutics. Iria’s leading technology, Active Tissue Targeting via Anchored Click Chemistry (ATTACK), is an innovative cancer-targeting technology that selectively labels cancer cells with proprietary unnatural sugars and targets the artificial label for improved drug delivery. The technology shows excellent improvement for tumor-targeted drug accumulation with significantly improved efficacy and lower side effects. Iria is actively seeking commercial partners and strategic collaborators for translational research and development.

iriapharma.com

Iria Pharma at Research Park